Nuzenio

Janux Therapeutics Inc

Janux Therapeutics Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 18 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Bank of America Securities Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 10:58:00 GMTJANX Stock Edges Up After Hours After Discontinuing Cancer Program In Favor Of Remaining Pipeline - StocktwitsStocktwits · Fri, 07 Aug 2026 15:37:43 GMTJanux Therapeutics, Inc. Stock 12‑Month Price Target Cut to $33.25, Implies 107% Upside - TradingViewTradingView · Fri, 07 Aug 2026 14:20:17 GMTJanux Therapeutics, Inc. (JANX) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 06 Aug 2026 23:06:38 GMTJanux Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:59:46 GMTJanux Therapeutics 2Q 2026: Revenue $10.3M, EPS $(0.35) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTJANX: Clinical pipeline advanced and net loss narrowed, supported by nearly $1B in liquidity - TradingViewTradingView · Thu, 06 Aug 2026 20:28:46 GMTJANX: Revenue from BMS collaboration boosted H1 2026 results; net loss narrowed, cash remains strong - TradingViewTradingView · Thu, 06 Aug 2026 20:20:46 GMT

Timeline

Sat, 08 Aug 2026 10:58:00 GMTBank of America Securities Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX) - The Globe and Mail
Fri, 07 Aug 2026 15:37:43 GMTJANX Stock Edges Up After Hours After Discontinuing Cancer Program In Favor Of Remaining Pipeline - Stocktwits
Fri, 07 Aug 2026 14:20:17 GMTJanux Therapeutics, Inc. Stock 12‑Month Price Target Cut to $33.25, Implies 107% Upside - TradingView
Thu, 06 Aug 2026 23:06:38 GMTJanux Therapeutics, Inc. (JANX) stock price, news, quote and history - Yahoo Finance Singapore
Thu, 06 Aug 2026 20:59:46 GMTJanux Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 20:35:07 GMTJanux Therapeutics 2Q 2026: Revenue $10.3M, EPS $(0.35) — 10-Q Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Janux Therapeutics Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.